Companies: 10,795·Total market cap: $144.5T

Bio-Path Holdings, Inc.

Bio-Path Holdings, Inc.

BPTHOTCHealthcare● Active

$0.03

$-0.00(-8.57%)

Market Cap$298949

P/E Ratio—

52W High$0.23

52W Low$0.01

Avg Volume28K

Open$0.05

Beta-0.41

Net Income Financials Revenue

Bio-Path Holdings, Inc. (BPTH) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

BPTH · net income · updated Jun 9, 2026

Core profitability metrics

BPTH · net income · margin · TTM · CAGR

Net income was −$8.7M for FY2025 (fiscal year ending 2025-12-31), up 12.3% year-over-year. Net profit margin was —.

FY2025 Net Income−$8.7M▲ +12.3% YoY

Trailing 12M (TTM)−$6.1Mtrailing 4 quarters sum

Net Profit Margin——

YoY Change+12.3%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · BPTH net income history · BPTH profit margin

Annual net income data

BPTH · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$8.7M▲ +12.3%—$0

FY2024Loss−$9.9M▲ +38.5%—$0

FY2023Loss−$16.1M▼ 16.2%—$0

FY2022Loss−$13.8M▼ 32.6%—$0

FY2021Loss−$10.4M▲ +3.9%—$0

Net income vs peers (Healthcare)

BPTH vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

Bio-Path Holdings, Inc.YOU

BPTH

−$8.7M+12.3%—

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Bio-Path Holdings, Inc. (BPTH) reported net income of −$8.7M for FY2025 (fiscal year ending 2025-12-31), up 12.3% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

Bio-Path Holdings, Inc. has not yet achieved annual profitability based on available data (15 fiscal years). The company has reported net losses across all available periods.

Bio-Path Holdings, Inc.'s net profit margin was — for FY2025, based on the latest annual results.

Investors sometimes search for "Bio-Path Holdings, Inc. net worth" — the company's market capitalization is a separate figure from BPTH net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

BPTH net income · 4 questions

Bio-Path Holdings, Inc. is not currently profitable on an annual basis. The company reported a net loss of $8.7M for FY2025.

is BPTH profitabledoes BPTH make a profitBPTH profitabilityBPTH profitable company

▸ Source: FMP /income-statement · GAAP · Bio-Path Holdings, Inc. · Bio-Path Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026